Panagora Asset Management Inc Biomarin Pharmaceutical Inc Transaction History

Panagora Asset Management Inc

$20.5 Billion
Q3 2024

A detailed history of Panagora Asset Management Inc transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Panagora Asset Management Inc holds 27,529 shares of BMRN stock, worth $1.83 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

27,529

Previous 14,055 95.87%

Holding current value

$1.83 Million

Previous $1.16 Million 67.24%

% of portfolio

0.01%

Previous 0.01%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$69.02 - $93.84 $929,975 - $1.26 Million	13,474 Added 95.87%	27,529 $1.94 Million
Q2 2024 Jul 29, 2024	SELL	$74.43 - $92.22 $282,982 - $350,620	-3,802 Reduced 21.29%	14,055 $1.16 Million
Q1 2024 May 07, 2024	SELL	$83.81 - $99.0 $717,497 - $847,539	-8,561 Reduced 32.41%	17,857 $1.56 Million
Q4 2023 Feb 08, 2024	BUY	$76.22 - $98.51 $89,406 - $115,552	1,173 Added 4.65%	26,418 $2.55 Million
Q3 2023 Oct 31, 2023	BUY	$85.07 - $94.48 $677,752 - $752,722	7,967 Added 46.11%	25,245 $2.23 Million
Q2 2023 Aug 11, 2023	SELL	$86.68 - $100.3 $1.55 Million - $1.8 Million	-17,922 Reduced 50.91%	17,278 $1.5 Million
Q1 2023 May 11, 2023	BUY	$87.74 - $117.27 $1.55 Million - $2.08 Million	17,719 Added 101.36%	35,200 $3.42 Million
Q4 2022 Feb 13, 2023	SELL	$80.93 - $108.63 $316,840 - $425,286	-3,915 Reduced 18.3%	17,481 $1.81 Million
Q3 2022 Nov 14, 2022	BUY	$82.16 - $96.94 $721,857 - $851,714	8,786 Added 69.67%	21,396 $1.81 Million
Q2 2022 Aug 15, 2022	BUY	$71.48 - $86.85 $168,764 - $205,052	2,361 Added 23.04%	12,610 $1.05 Million
Q1 2022 May 12, 2022	SELL	$74.28 - $92.69 $15,747 - $19,650	-212 Reduced 2.03%	10,249 $790,000
Q4 2021 Feb 10, 2022	SELL	$71.72 - $91.47 $108,512 - $138,394	-1,513 Reduced 12.64%	10,461 $924,000
Q3 2021 Nov 10, 2021	SELL	$74.77 - $85.47 $10,542 - $12,051	-141 Reduced 1.16%	11,974 $925,000
Q2 2021 Aug 11, 2021	SELL	$75.51 - $84.79 $43,795 - $49,178	-580 Reduced 4.57%	12,115 $1.01 Million
Q1 2021 May 12, 2021	BUY	$74.73 - $90.69 $99,465 - $120,708	1,331 Added 11.71%	12,695 $959,000
Q4 2020 Feb 10, 2021	BUY	$72.61 - $90.2 $212,747 - $264,286	2,930 Added 34.74%	11,364 $996,000
Q3 2020 Nov 13, 2020	BUY	$71.87 - $131.03 $378,179 - $689,479	5,262 Added 165.89%	8,434 $642,000
Q2 2020 Aug 12, 2020	BUY	$79.55 - $124.22 $12,489 - $19,502	157 Added 5.21%	3,172 $391,000
Q4 2019 Feb 12, 2020	BUY	$64.27 - $86.37 $26,672 - $35,843	415 Added 15.96%	3,015 $255,000
Q3 2019 Nov 12, 2019	SELL	$67.4 - $85.11 $123,342 - $155,751	-1,830 Reduced 41.31%	2,600 $175,000
Q2 2019 Aug 09, 2019	SELL	$80.35 - $93.9 $10,927 - $12,770	-136 Reduced 2.98%	4,430 $379,000
Q1 2018 May 15, 2018	SELL	$77.67 - $92.63 $47,767 - $56,967	-615 Reduced 11.87%	4,566 $370,000
Q4 2017 Feb 14, 2018	SELL	$80.76 - $95.13 $53,786 - $63,356	-666 Reduced 11.39%	5,181 $462,000
Q3 2017 Nov 14, 2017	BUY	$80.6 - $94.95 $471,268 - $555,172	5,847	5,847 $544,000

Others Institutions Holding BMRN

# of Institutions

637

Shares Held

177M

Call Options Held

2.01M

Put Options Held

1.28M

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $12.4B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Panagora Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Panagora Asset Management Inc with notifications on news.

Account

Panagora Asset Management Inc Biomarin Pharmaceutical Inc Transaction History